isoxazoles has been researched along with Blood Poisoning in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Guo, Y; Min, S; Wu, B | 1 |
| Chu, X; Han, Y; Li, C; Mu, S; Qiu, D; Song, Z; Tong, C; Wang, J; Wei, W; Zhu, M | 1 |
| Cao, L; Che, Y; Gonzalez, FJ; Hao, H; Jiang, C; Takahashi, S; Wang, G; Zhang, S | 1 |
| Chi, Z; Guo, C; Huang, B; Wang, D; Wu, Y; Xia, D; Xie, S | 1 |
| Bhatti, R; Gupta, M; Kumar, A; Sharma, A; Singh Ishar, MP; Singh, G | 1 |
| Fadillioglu, E; Karaman, A; Ozturk, E; Samdancı, E; Surucu, M | 1 |
| Clement, HW; Jargon, D; Schulz, K; Sommer, O; Strate, T; Utzolino, S; von Dobschuetz, E | 1 |
| Huang, H; Jacko, AM; Tsung, A; Weathington, N; Wei, J; Zhao, J; Zhao, Y | 1 |
| Begec, Z; Demirbilek, S; Ersoy, MO; Fadillioglu, E; Kirimlioglu, H; Ozturk, E; Surucu, M | 1 |
| Bosselmann, S; Chada, M; Gessner, A; Kandler, M; Nögel, SC; Rascher, W; Schmidt, AM; Schneider, H; Schweer, H; Watzer, B | 1 |
| Al-Abed, Y; Aljabari, B; Bacher, M; Dabideen, D; Messmer, D; Metz, C; Miller, EJ; Nicoletti, F; Ochani, K; Ochani, M; Pavlov, VA; Tanovic, M; Tracey, KJ; Valster, A | 1 |
| Al-Abed, Y; Kohn, N; Lin, X; Metz, CN; Miller, EJ; Ojamaa, K; Sakuragi, T | 1 |
| Chapman, PT; Jenks, KA; O'Donnell, JL; Savage, RL; Stamp, LK | 1 |
| Broom, NJ; Elder, JS; Hannan, PC; O'Hanlon, PJ; Pons, JE; Walker, G; Wilson, J; Woodall, P | 1 |
| Pokrovskiĭ, VI; Timina, VP | 1 |
15 other study(ies) available for isoxazoles and Blood Poisoning
| Article | Year |
|---|---|
Parecoxib ameliorates renal toxicity and injury in sepsis-induced mouse model and LPS-induced HK-2 cells.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cyclooxygenase 2; Disease Models, Animal; I-kappa B Kinase; Inflammation; Isoxazoles; Lipopolysaccharides; Mice; NF-kappa B; Sepsis | 2022 |
The increased marginal zone B cells attenuates early inflammatory responses during sepsis in Gpr174 deficient mice.
Topics: Animals; B-Lymphocytes; Benzophenones; Disease Models, Animal; Humans; Isoxazoles; Lipopolysaccharides; Mice; Mice, Knockout; Proto-Oncogene Proteins c-fos; Receptors, G-Protein-Coupled; RNA-Seq; Sepsis; Signal Transduction; Spleen; Up-Regulation | 2020 |
Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis.
Topics: Animals; Bile Acids and Salts; Calcium; Caspase 1; Cholestasis; Humans; Inflammasomes; Isoxazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Models, Biological; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Binding; RAW 264.7 Cells; Receptors, Cytoplasmic and Nuclear; Sepsis | 2017 |
A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism.
Topics: Alum Compounds; Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Humans; Inflammasomes; Isoxazoles; Leukocytes, Mononuclear; Macrophages; Male; Mice; Mice, Inbred C57BL; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Peritonitis; Protein Multimerization; Receptors, Cytoplasmic and Nuclear; Sepsis; Ubiquitination | 2017 |
Indolyl-isoxazolidines attenuate LPS-stimulated pro-inflammatory cytokines and increase survival in a mouse model of sepsis: Identification of potent lead.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Inflammation; Interleukin-6; Isoxazoles; Lipopolysaccharides; Mice; Sepsis; Tumor Necrosis Factor-alpha | 2018 |
Protective effect of leflunomide against oxidative intestinal injury in a rodent model of sepsis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Catalase; Cecum; Disease Models, Animal; Intestinal Mucosa; Intestines; Isoxazoles; Leflunomide; Male; Malondialdehyde; Multiple Organ Failure; Nitric Oxide; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase | 2014 |
Cytokine and radical inhibition in septic intestinal barrier failure.
Topics: Animals; Cyclic N-Oxides; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Free Radical Scavengers; Interleukin-6; Intestinal Mucosa; Isoxazoles; Lipopolysaccharides; Male; Multiple Organ Failure; NADPH Oxidases; Neutrophils; Permeability; Pyruvic Acid; Rats, Sprague-Dawley; Sepsis; Spin Labels; Vasoactive Intestinal Peptide | 2015 |
Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
Topics: Alanine Transaminase; Animals; Apoptosis; Cell Line; Cytokines; Disease Models, Animal; HEK293 Cells; Hep G2 Cells; Humans; Isoxazoles; Lipopolysaccharide Receptors; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Peritonitis; Peroxidase; Propionates; Receptors, Lysophosphatidic Acid; Sepsis; Signal Transduction; Translational Research, Biomedical | 2015 |
Does leflunomide attenuate the sepsis-induced acute lung injury?
Topics: Acute Lung Injury; Adjuvants, Immunologic; Animals; Disease Models, Animal; Glutathione; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Sepsis; Spectrophotometry; Superoxide Dismutase; Treatment Outcome | 2008 |
Parecoxib does not suppress thromboxane synthesis in newborn piglets with group B streptococcal sepsis.
Topics: Animals; Animals, Newborn; Cyclooxygenase 2 Inhibitors; Dinoprostone; Epoprostenol; Gene Expression Regulation; Hemodynamics; Indomethacin; Inflammation; Isoxazoles; Lung; Platelet Count; Receptors, Prostaglandin E; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxanes | 2009 |
ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Cecum; Cell Survival; Electrophoretic Mobility Shift Assay; Endotoxemia; Intramolecular Oxidoreductases; Isoxazoles; Lipopolysaccharides; Macrophage Migration-Inhibitory Factors; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Punctures; Sepsis; Survival Rate; Tumor Necrosis Factors | 2005 |
Lung-derived macrophage migration inhibitory factor in sepsis induces cardio-circulatory depression.
Topics: Animals; Cardiac Volume; Disease Models, Animal; Echocardiography; Immunologic Factors; Isoxazoles; Lung; Macrophage Migration-Inhibitory Factors; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Sepsis; Shock; Stroke Volume | 2007 |
Leflunomide-associated infections in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cellulitis; Female; Hospitalization; Humans; Infections; Isoxazoles; Leflunomide; Male; Middle Aged; New Zealand; Sepsis; Staphylococcal Infections; Tuberculosis, Hepatic | 2007 |
The chemistry of pseudomonic acid. Part 14. Synthesis and in vivo biological activity of heterocyclyl substituted oxazole derivatives.
Topics: Animals; Anti-Bacterial Agents; Furans; Humans; Isoxazoles; Mice; Mupirocin; Oxazoles; Pyrazoles; Pyridines; Sepsis; Staphylococcal Infections; Thiazoles; Thiophenes | 1995 |
[Antibiotics in the clinical aspects of infectious diseases].
Topics: Ampicillin; Anti-Bacterial Agents; Antibody Formation; Chloramphenicol; Chronic Disease; Communicable Diseases; Drug Therapy, Combination; Erythromycin; Genetics, Microbial; Humans; Isoxazoles; Methicillin; Microbial Sensitivity Tests; Oleandomycin; Penicillin Resistance; Penicillins; Recurrence; Sepsis; Tetracycline | 1974 |